No black box warning on record for Vasopressin In 0.9% Sodium Chloride

As of the latest FDA labeling reviewed, Vasopressin In 0.9% Sodium Chloride (VASOPRESSIN IN 0.9% SODIUM CHLORIDE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Vasopressin In 0.9% Sodium Chloride medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Can worsen cardiac function ( 5.1 ) • Reversible diabetes insipidus ( 5.2 ) 5.1 Worsening Cardiac Function A decrease in cardiac index may be observed with the use of vasopressin. 5.2 Reversible Diabetes Insipidus Patients may experience reversible diabetes insipidus, manifested by the development of polyuria, a dilute urine, and hypernatremia, after cessation of treat

No black box warning on record for Vasopressin In 0.9% Sodium Chloride

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Can worsen cardiac function ( 5.1 ) • Reversible diabetes insipidus ( 5.2 ) 5.1 Worsening Cardiac Function A decrease in cardiac index may be observed with the use of vasopressin. 5.2 Reversible Diabetes Insipidus Patients may experience reversible diabetes insipidus, manifested by the development of polyuria, a dilute urine, and hypernatremia, after cessation of treat

Vasopressin In 0.9% Sodium Chloride Black Box Warning

No black box warning on record for Vasopressin In 0.9% Sodium Chloride

Other warnings & precautions

Vasopressin In 0.9% Sodium Chloride Black Box Warning

No black box warning on record for Vasopressin In 0.9% Sodium Chloride

Other warnings & precautions